Swiss Electrical Stock News

EMS-CHEMIE Holding (SWX:EMSN) has put fresh numbers on the table for FY 2025, with second half revenue of CHF 930.4 million, basic EPS of CHF 9.26 and net income of CHF 216.6 million, while trailing 12 month figures sit at CHF 1.95 billion of revenue, EPS of CHF 19.97 and net income of CHF 467 million. The company has seen revenue move from CHF 1,004.0 million and EPS of CHF 9.04 in the second half of 2024 to CHF 1,019.6 million and EPS of CHF 10.71 in the first half of 2025, before landing...

Q3 2026 results set the stage for a margin focused story LEM Holding (SWX:LEHN) has put fresh numbers on the table for Q3 2026, with revenue at CHF70.1 million, net income at CHF5.3 million and basic EPS of CHF4.64, while trailing 12 month figures show revenue of CHF294.4 million, net income of CHF8.4 million and EPS of CHF7.36 alongside forecast annual earnings growth of 45.9%. Over recent quarters the company has seen revenue move from CHF75.6 million in Q2 2025 to CHF76.0 million in Q4...

Why Vontobel’s latest earnings and dividend matter Vontobel Holding (SWX:VONN) has drawn fresh investor attention after reporting higher full year 2025 net income and earnings per share, together with asset under management growth and an affirmed annual dividend of CHF 3.00 per share. See our latest analysis for Vontobel Holding. The earnings and dividend announcement has coincided with a clear upswing in sentiment, with a 3.83% 1 day share price return and a 16.12% 90 day share price return...

Revenue growth event puts Compagnie Financière Tradition (SWX:CFT) in focus Compagnie Financière Tradition (SWX:CFT) caught investor attention after reporting 2025 consolidated revenue growth of 11.4% at constant exchange rates, with the fourth quarter advancing 11.7% on higher transaction volumes across asset classes and regions. See our latest analysis for Compagnie Financière Tradition. At a share price of CHF289.0, Compagnie Financière Tradition has had a mixed shorter term run, with a 1...

CEO transition puts SIG Group in focus SIG Group (SWX:SIGN) has confirmed that Mikko Keto will become CEO on 1 March 2026, while interim CEO Anne Erkens will return to her CFO role. This planned transition is being closely watched by shareholders. See our latest analysis for SIG Group. At a share price of CHF12.0, SIG Group has seen a 44.84% 90 day share price return. However, its 1 year total shareholder return of 36.91% indicates that longer term momentum has been weak and sentiment is...

UBS Group (SWX:UBSG) is back in focus after its Q4 2025 report showed net income of US$1.2b and full year profit of US$7.8b, along with progress on the Credit Suisse integration. See our latest analysis for UBS Group. The latest Q4 results, higher proposed dividend and the new share repurchase plan have arrived after a mixed run in the share price, with a 30 day share price return of 9.4% decline but a 90 day share price return of 11.53% and a 1 year total shareholder return of 14.88%,...

Most readers would already know that Burkhalter Holding's (VTX:BRKN) stock increased by 8.1% over the past three...

It's been a good week for Novartis AG ( VTX:NOVN ) shareholders, because the company has just released its latest...

Why Holcim’s new solar PPA in the Philippines matters for shareholders Holcim (SWX:HOLN) has signed a 20 year Power Purchase Agreement with Peak Energy to build a large behind the meter solar project for its cement plants in the Philippines, tying long term energy costs directly to renewable power. The 25 MegaWatt peak installation is expected to supply around 40 gigawatt hours of electricity a year to the Bacnotan and Norzagaray facilities, with Holcim buying the output while Peak Energy...

Swiss Prime Site (SWX:SPSN) has released its FY 2025 numbers with first half revenue of CHF 276.9m, basic EPS of CHF 2.07 and FFO per share of CHF 2.09, setting the tone for the year. The company has seen revenue move from CHF 318.9m in the first half of 2024 to CHF 352.1m in the second half of 2024 and then to CHF 276.9m in the first half of 2025. Basic EPS shifted from CHF 2.14 to CHF 2.53 over 2024 and then to CHF 2.07 in early 2025, leaving investors to weigh these headline trends against...

Why the new CFO appointment matters for Forbo Holding Forbo Holding (SWX:FORN) has appointed Heinz Hössli as Chief Financial Officer from 1 July 2026, a leadership change that puts the company’s financial direction and capital allocation firmly in the spotlight for investors. See our latest analysis for Forbo Holding. Forbo Holding’s recent CFO announcement lands after a strong run in the share price, with a 90 day share price return of 35% and a 1 year total shareholder return of 12.04%,...

What ABB’s Recent Run Means For Its Valuation ABB’s share price story can look impressive at first glance, so if you are wondering whether the stock still offers value, it helps to separate the headlines from the actual numbers. Over the last week ABB’s return was 0.1%, over the last month it was 9.5%, year to date it was 8.5%, and over the last year it was 36.6%, with a 3 year return of 128.2% and a 5 year return of 204.3%. This raises fair questions about how much of the good news might...

Barry Callebaut (SWX:BARN) is back in focus after reporting a 22% drop in cocoa division sales volume for the quarter ending November 30, citing weak market demand and a tilt toward higher return cocoa segments. See our latest analysis for Barry Callebaut. The latest cocoa volume setback comes after a period of strong momentum in the share price, with a 12.69% 1 month share price return and an 18.16% 3 month share price return contributing to a 45.54% 1 year total shareholder return, even...

While Zehnder Group AG ( VTX:ZEHN ) might not have the largest market cap around , it led the SWX gainers with a...

As of early 2026, the European markets are showing signs of cautious optimism, with the pan-European STOXX Europe 600 Index experiencing modest gains driven by positive earnings forecasts despite ongoing trade and geopolitical concerns. In this environment, growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management and shareholder interests, as these companies may benefit from strong internal commitment to long-term success.

Novartis (SWX:NOVN) has wrapped up FY 2025 with fourth quarter revenue of US$13.9b and basic EPS of US$1.26, while trailing twelve month revenue sits at US$56.7b with EPS of US$7.21. Over the past year, revenue has moved from US$51.7b to US$56.7b on a trailing basis and EPS has shifted from US$5.92 to US$7.21. This gives you a clear read on how the top line and per share profitability have tracked together. With net margin at 24.7% over the last twelve months and the current share price at...

UBS Group FY 2025 Earnings Snapshot UBS Group (SWX:UBSG) closed out FY 2025 with Q4 revenue of US$12.2 billion, basic EPS of US$0.36 and net income of US$1,199 million, rounding off a year where trailing twelve month revenue came in at US$49.1 billion, EPS was US$2.36 and net income reached US$7,767 million. The bank has seen quarterly revenue move from US$11.4 billion and EPS of US$0.24 in Q4 2024 to a range of US$11.9 billion to US$12.5 billion and EPS between US$0.53 and US$0.79 through...

Most readers would already be aware that Swiss Prime Site's (VTX:SPSN) stock increased significantly by 15% over the...

Nestlé (SWX:NESN) initiated a major precautionary recall of certain infant formula products in the UK. The recall follows regulatory confirmation of potential toxin contamination traced to a shared ingredient supplier. Clinical cases among children have been reported, prompting heightened scrutiny from health authorities. The move raises questions around product safety controls, supplier oversight, and consumer confidence in Nestlé’s infant nutrition portfolio. Nestlé is one of the largest...

Roche Holding reported highly positive topline Phase 2 results for its anti obesity drug candidate CT-388 and plans to start Phase 3 trials this quarter. The company also announced a collaboration between Roche Diagnostics and ChemoMetec to develop bioprocess monitoring solutions combining their technologies. Roche Holding (SWX:ROG) is drawing fresh attention after these updates, with its shares at CHF358.7 and a value score of 5. The stock has returned 3.4% over the past week and 8.7% over...

Wondering whether Clariant's share price around CHF 8.25 actually represents good value, or if the market is missing something you should not ignore? The stock has returned 13.2% over the last 7 days and 15.9% over the last 30 days and year to date, although the 1 year, 3 year and 5 year returns of 13.7%, 42.1% and 49.3% declines show a tougher longer term picture. Recent moves come against a backdrop of ongoing interest in chemical producers' portfolio reshaping, cost structures and...

Givaudan SA recently reported its full-year 2025 results, with sales of CHF 7,472 million and net income of CHF 1,071 million, and announced an annual dividend of CHF 72.00 per share payable on March 25, 2026. Despite slightly lower net income and earnings per share than the previous year, the decision to raise the dividend highlights management’s willingness to return more cash to shareholders. We will now examine how Givaudan’s decision to increase its annual dividend despite softer...

Sandoz Group (SWX:SDZ) is back in focus after Sandoz Canada introduced Enzeevu, its first ophthalmology biosimilar to Eylea, marking an entry into retinal treatments that broadens the group’s biosimilar footprint. See our latest analysis for Sandoz Group. At a share price of CHF61.2, Sandoz Group has posted a 30 day share price return of 6.96% and a 90 day share price return of 12.83%. Its 1 year total shareholder return of 43.19% suggests momentum has been building, with the Enzeevu launch...

Alcon recently launched its PRECISION7 sphere and toric weekly replacement contact lenses in Canada, featuring the ACTIV-FLO System designed to deliver 16 hours of comfort and precise vision through day seven. By combining a one-week replacement schedule with a cost-conscious alternative to daily disposables, PRECISION7 targets a large segment of reusable lens wearers who value both comfort and simplicity. Next, we’ll examine how introducing a weekly replacement lens with the ACTIV-FLO...